Home/Pipeline/Generic OTC Product Development

Generic OTC Product Development

Various Consumer Health (e.g., Antacid, Fiber Therapy)

CommercialActive

Key Facts

Indication
Various Consumer Health (e.g., Antacid, Fiber Therapy)
Phase
Commercial
Status
Active
Companies

About Raritan Pharmaceuticals

Raritan Pharmaceuticals operates as a specialized contract manufacturer and developer in the consumer healthcare space, with expertise in tablets, capsules, liquids, creams, and film-delivery systems. The company targets the OTC, medical device, and therapeutic cosmetics markets, emphasizing speed-to-market, quality, and kosher certification for many products. While presenting itself with broad sector claims, its core business appears to be contract services and generic OTC product manufacturing rather than novel therapeutic discovery. Key strategic focuses include taste-masked formulations and first-to-market generic OTC launches.

View full company profile

About PannonPharma

PannonPharma is a privately-held, commercial-stage Hungarian generics and OTC pharmaceutical company. It operates with an integrated business model encompassing GMP manufacturing (both for its own products and contract manufacturing), pharmaceutical R&D, quality control, and distribution. The company leverages its heritage and local roots, emphasizing quality ('Tradition, Quality!') and a broad portfolio targeting common respiratory, dermatological, and inflammatory conditions. Its strategy focuses on serving the Hungarian and potentially regional markets with affordable, accessible medicines while investing in R&D and plant modernization.

View full company profile